The future of
single-domain antibodies



Cell biology

We asked Hybrigenics to select intrabodies against four different proteins involved in vesicular trafficking. They quickly provided us with several candidates per protein, in the form of ready-to-use plasmids for mammalian expression. We already validated some of these intrabodies. Fused to a red fluorescent protein, they will be extremely valuable tools to block our target proteins in live cells — Dr. Thierry Galli (Jacques Monod Institute, Paris, France) - Europe

Back to testimonials

Back to Top